Efficacy News and Research

RSS
Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

New method for improving cord blood transplant success

New method for improving cord blood transplant success

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare receives FDA approval for Adempas tablets

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

MNK-795 for acute pain management: an interview with Dr Lynn Webster

MNK-795 for acute pain management: an interview with Dr Lynn Webster

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Brain & Behavior Research Foundation to hold research symposium on mental health

Brain & Behavior Research Foundation to hold research symposium on mental health

Researchers use ARRAYit Microarray Platform to discover important biomarkers

Researchers use ARRAYit Microarray Platform to discover important biomarkers

Researchers examine probiotics to prevent excessive crying in infants

Researchers examine probiotics to prevent excessive crying in infants

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Novel sensing algorithm detects effect of AD in unconstrained everyday motion behavior

Novel sensing algorithm detects effect of AD in unconstrained everyday motion behavior

Newly discovered compound could be developed as antifungal drug to treat fungal infections

Newly discovered compound could be developed as antifungal drug to treat fungal infections

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

MIT investigators receive DARPA grant to develop new technologies for BioMOD program

MIT investigators receive DARPA grant to develop new technologies for BioMOD program

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.